METOZOLV Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Metozolv, and when can generic versions of Metozolv launch?
Metozolv is a drug marketed by Salix Pharms and is included in one NDA.
The generic ingredient in METOZOLV is metoclopramide hydrochloride. There are fourteen drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the metoclopramide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Metozolv
A generic version of METOZOLV was approved as metoclopramide hydrochloride by TEVA on July 29th, 1985.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for METOZOLV?
- What are the global sales for METOZOLV?
- What is Average Wholesale Price for METOZOLV?
Summary for METOZOLV
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | METOZOLV at DailyMed |
US Patents and Regulatory Information for METOZOLV
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Salix Pharms | METOZOLV ODT | metoclopramide hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 022246-001 | Sep 4, 2009 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Salix Pharms | METOZOLV ODT | metoclopramide hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 022246-002 | Sep 4, 2009 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
